D’OXYVA improves dermal microcirculation and promotes wound healing in the diabetic foot (clinical trial update)
Prof. Puruhito and colleagues have released the results of three observational trials showing that D’OXYVA® (Circularity Healthcare LLC), a deoxyhemoglobin vasodilator, improves vasodilation in the treatment of